Skip to main content
HK inno.N Corporation logo

HK inno.N Corporation — Investor Relations & Filings

Ticker · 195940 ISIN · KR7195940002 KO Manufacturing
Open in API
Filings indexed 256 across all filing types
Latest filing 2025-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 195940

About HK inno.N Corporation

https://www.inno-n.com/eng

HK inno.N Corporation is a biohealth company engaged in the development, manufacturing, and distribution of pharmaceutical and consumer healthcare products. The company operates through two main divisions: Specialty Medicines and Health & Beauty (H&B). The Specialty Medicines division focuses on prescription drugs, with research and development centered on novel treatments for gastrointestinal diseases, immune diseases, and cancer. Its bio-research efforts also include vaccines and next-generation cell and gene therapies. The Health & Beauty division provides consumer products such as health functional foods and beauty items, supported by dedicated research into new materials and ingredients. The company leverages its integrated R&D capabilities to offer innovative solutions across both its pharmaceutical and consumer health markets.

Recent filings

Filing Released Lang Actions
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for HK inno.N Corporation, covering the period from January 1, 2025, to March 31, 2025. It contains detailed financial data, business operations, and management information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-15 Korean
투자판단관련주요경영사항(임상시험계획승인신청등결정) (IN-B00009의 제3상 임상시험계획 승인)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from HK inno.N regarding the approval of a Phase 3 clinical trial (IN-B00009) by the Ministry of Food and Drug Safety. It is a formal disclosure of a material management event (clinical trial approval) submitted to the Korea Exchange (KRX). Since it does not fit into specific categories like financial reports, dividends, or director dealings, and is a standard regulatory disclosure of a business event, it is classified as a Regulatory Filing (RNS).
2025-05-07 Korean
소속부변경
Regulatory Filings Classification · 100% confidence The document is a short regulatory notice from HK inno.N regarding a change in the company's listing status (from 'Mid-sized Enterprise' to 'Blue-chip Enterprise') on the stock exchange. Since it is a brief regulatory announcement that does not fit into specific categories like financial reports, dividends, or M&A, it falls under the general regulatory filing category.
2025-04-30 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Preliminary Earnings Release' (영업(잠정)실적) for HK inno.N, detailing quarterly financial performance (revenue, operating profit, net income) for 2025 Q1. It provides key financial highlights and comparisons to previous periods, which is the standard format for an Earnings Release (ER). It is not a full report, but rather the initial announcement of financial results. Q1 2025
2025-04-28 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement regarding the scheduling of an investor relations (IR) conference call to discuss Q1 2025 financial results. It provides the date, time, location, and purpose of the event. Since it is an announcement of an upcoming event and the availability of materials rather than the actual financial report or the transcript itself, it falls under the category of a Report Publication Announcement or general regulatory filing notification.
2025-04-28 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement regarding the scheduling of an Investor Relations (IR) meeting (NDR - Non-Deal Roadshow). It provides details such as date, location, purpose, and contact information, and mentions that IR materials are available on the company website. Since it is an announcement of an event rather than the presentation itself, and it fits the criteria for a regulatory announcement regarding corporate activities, it is classified as a Regulatory Filing (RNS).
2025-04-28 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.